Orbital myositis secondary to statin therapy

Bobak Bahrami, Saul Rajak and Dinesh Selva
Med J Aust 2015; 203 (9): . || doi: 10.5694/mja15.00503
Published online: 2 November 2015

A 45-year-old man presented with a 3-month history of diplopia and pain on left downgaze, increasing left upper lid oedema, and erythema. Eye movements were full and visual acuity and intraocular pressure normal. His regular medications, both commenced 4 months before presentation, were simvastatin (20 mg/day) and aspirin (100 mg/day). A complete blood count, thyroid function and auto-antibodies, inflammatory markers and creatine kinase were all unremarkable, as was an autoimmune screen. Orbital computed tomography showed left medial rectus and superior oblique enlargement.

  • Royal Adelaide Hospital, Adelaide, SA


Competing interests:

No relevant disclosures.

  • 1. Fraser CL, Skalicky SE, Gurbaxani A, McCluskey P. Ocular myositis. Curr Allergy Asthma Rep 2013; 13: 315-321.
  • 2. Abd TT, Jacobson TA. Statin-induced myopathy: a review and update. Expert Opin Drug Saf 2011; 10: 373-387.
  • 3. Fraunfelder FW, Richards AB. Diplopia, blepharoptosis, and ophthalmoplegia and 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitor use. Ophthalmology 2008; 115: 2282-2285.
  • 4. Garcia-Cazarin ML, Fisher TM, Andrade FH. Glucose uptake in rat extraocular muscles: effect of insulin and contractile activity. Invest Ophthalmol Vis Sci 2010; 51: 6364-6368.
  • 5. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239-245.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.